Obesity Trial, Recruiting NCT07094568 Sponsor: National and Kapodistrian University of Athens Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07094568
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between the ages of 30 and 65 years
  • People with a BMI (body mass index) of 40 or higher, which is a measure of body weight relative to height

Who may not be able to join:

  • People who have been diagnosed with Type 1 or Type 2 diabetes
  • People who have chronic kidney disease
  • People who have liver failure
  • People who have heart failure
  • People who have an active cancer diagnosis
  • People who have previously had weight-loss (bariatric) surgery or any bowel surgery that involved rerouting the intestines
  • People with an underactive or overactive thyroid that is not well controlled with treatment
  • People with an underactive or overactive parathyroid gland (small glands in the neck) that is not well controlled with treatment
  • People who are currently pregnant or breastfeeding
  • People who have had a bone fracture within the last 2 years
  • People who have rare bone metabolism conditions such as Paget's disease of bone, fibrous dysplasia, or osteopetrosis
  • People who have inflammatory arthritis (such as rheumatoid arthritis)
  • People currently taking certain medications that can affect bone health markers, including bone-building drugs, bone-protecting drugs, some hormone-related medications, blood thinners of a specific type, antipsychotic medications, contraceptives, oral steroids, methotrexate, certain blood pressure medications, or hormone-blocking cancer treatments (confirm full medication list with trial site)
  • People who have a condition called hemolytic anemia, where red blood cells are destroyed faster than the body can replace them

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +306986606272

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National and Kapodistrian University of Athens
Registry
ClinicalTrials.gov
Start date
23 May 2025
Est. completion
30 December 2026

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Change in serum CTX concentration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov